Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Baricitinib can cause excessive hair growth.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Taking riboflavin and eating less lysine can help some people with a specific genetic disorder avoid brain damage.

TIP39 and PTH2R help control calcium levels and skin cell development.

The nanofiber membranes effectively promote wound healing and have strong antibacterial properties.

A new genetic mutation in the TRPS1 gene causes Trichorhinophalangeal Syndrome, leading to specific hair, dental, and bone issues.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Finasteride may help reduce COVID-19 infection by altering a key gene.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

A new mutation in the TRPS1 gene was found in a Ukrainian girl with Trichorhinophalangeal syndrome type I.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Rivaroxaban may cause hair loss.

Bortezomib chemotherapy can cause temporary skin rashes.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

CS12192 effectively treats alopecia areata with better safety than current options.